Kirk Knowlton
About Kirk Knowlton
Kirk Knowlton serves as the Associate Medical Director of Cardiovascular Research at Intermountain Health and holds a professorship at the University of Utah School of Medicine. He has extensive experience in cardiology, having previously worked at the University of California, San Diego, and has a strong research interest in pulmonary hypertension and related heart diseases.
Work at Intermountain Healthcare
Kirk Knowlton serves as the Associate Medical Director for Cardiovascular Research at Intermountain Health, a position he has held since 2022. He works at the Intermountain Medical Center, Heart Institute in Salt Lake City, Utah. In addition to his role as Associate Medical Director, he is also a Professor of Clinical Investigation at Intermountain Health, a position he has maintained since 2017. His responsibilities include overseeing cardiovascular research initiatives and contributing to the advancement of clinical practices within the organization.
Education and Expertise
Kirk Knowlton's educational background includes a Bachelor of Arts in Chemistry from Brigham Young University, completed in 1980. He earned his Doctor of Medicine (MD) degree from the University of Utah School of Medicine, where he studied from 1980 to 1984. He completed his Internal Medicine Residency Program during the same period. Following this, he pursued a Cardiology fellowship at UC San Diego from 1987 to 1991. His extensive training has equipped him with expertise in various aspects of cardiovascular medicine.
Background
Kirk Knowlton has a long-standing career in cardiology, having worked at the University of California at San Diego as a Professor of Medicine and Chief of Cardiology from 1991 to 2016. He later joined Intermountain Health, where he served as the Interim Chair of Cardiology at the Intermountain Heart Institute from 2019 to 2022. His professional journey reflects a commitment to both education and clinical practice in the field of cardiology.
Research Interests
Kirk Knowlton has a focused research interest in pulmonary hypertension related to thromboembolic disease, myocarditis, and hereditary heart disease. His work contributes to the understanding and treatment of these conditions, aiming to improve patient outcomes in cardiovascular health. His research is documented in various publications, including one listed on PubMed with the identifier 24200690.